Macular thickness mapping in exudative age-related macular degeneration

Retina

Volumn 26, Issue 1, 2006, Pages 44-48

  Shakoor, A ^a   Shahidi, M ^a   Blair, N P ^a   Gieser, J P ^a   Zelkha, R ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Age related macular degeneration (AMD); Choroidal neovascularization (CNV); Fluorescein angiography; Retinal thickness

Indexed keywords

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXUDATIVE RETINITIS; FLUORESCENCE ANGIOGRAPHY; HUMAN; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; THICKNESS; VITREORETINOPATHY; CAPILLARY PERMEABILITY; EXUDATE; PATHOLOGY; PHOTOCHEMOTHERAPY; RETINA MACULA DEGENERATION; RETINA MACULA LUTEA; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION;

AGED; CAPILLARY PERMEABILITY; CHOROIDAL NEOVASCULARIZATION; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; EXUDATES AND TRANSUDATES; FLUORESCEIN ANGIOGRAPHY; HUMANS; MACULA LUTEA; MACULAR DEGENERATION; PHOTOCHEMOTHERAPY; VISUAL ACUITY;

EID: 33644863883     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200601000-00008     Document Type: Article

References (24)

1. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 1992;99:933-943.
2. Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Surv Ophthalmol 1988;32:375-413.
3. Donati G, Kapetanios AD, Pournaras CJ. Principles of treatment of choroidal neovascularization with photodynamic therapy in age-related macular degeneration. Semin Ophthalmol 1999;14:2-10.
4. Harding S. Photodynamic therapy in the treatment of subfoveal choroidal neovascularisation. Eye 2001;15:407-412.
5. Schmidt-Erfurth U, Miller JW, Sickenberg M, et al. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Arch Ophthalmol 1999;117:1177-1187.
6. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials - TAP report. Arch Ophthalmol 1999;117:1329-1345.
7. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805-2816.
8. Lauer AK, Wilson DJ, Klein ML. Clinicopathologic correlation of fluorescein and indocyanine green angiography in exudative age-related macular degeneration. Retina 2000;20:492-499.
9. Kuck H, Inhoffen W, Schneider U, Kreissig I. Diagnosis of occult subretinal neovascularization in age-related macular degeneration by infrared scanning laser videoangiography. Retina 1993;13:36-39.
10. Hee MR, Baumal CR, Puliafito CA, et al. Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. Ophthalmology 1996;103:1260-1270.
11. Kim SG, Lee SC, Seong YS, Kim SW, Kwon OW. Choroidal neovascularization characteristics and its size in optical coherence tomography. Yonsei Med J 2003;44:821-827.
12. Giovannini A, Amato GP, Mariotti C, Scassellati-Sforzolini B. OCT imaging of choroidal neovascularisation and its role in the determination of patients' eligibility for surgery. Br J Ophthalmol 1999;83:438-442.
13. Rogers AH, Martidis A, Greenberg PB, Puliafito CA. Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization. Am J Ophthalmol 2002;134:566-576.
14. Gieser JP, Mori M, Blair NP, Shahidi M. Findings on retinal topography and thickness mapping in age-related macular degeneration. Retina 2001;21:352-360.
15. Montero JA, Ruiz-Moreno JM. Macular thickness in patients with choroidal neovascularization determined by RTA and OCT3: comparative results. Eye 2005;19:72-76.
16. Gieser JP, Rusin MM, Mori M, Blair NP, Shahidi M. Clinical assessment of the macula by retinal topography and thickness mapping. Am J Ophthalmol 1997;124:648-660.
17. Shahidi M, Blair NP, Mori M, Gieser J, Pulido JS. Retinal topography and thickness mapping in atrophic age related macular degeneration. Br J Ophthalmol 2002;86:623-626.
18. Zeimer R, Shahidi M, Mori M, Zou S, Asrani S. A new method for rapid mapping of the retinal thickness at the posterior pole. Invest Ophthalmol Vis Sci 1996;37:1994-2001.
19. McCaughan JS Jr. Photodynamic therapy: a review. Drugs Aging 1999;15:49-68.
20. Barbazetto I, Burdan A, Bressler NM, et al. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment - TAP and VIP report No. 2. Arch Ophthalmol 2003;121:1253-1268.
21. Fukuchi T, Takahashi K, Ida H, Sho K, Matsumura M. Staging of idiopathic choroidal neovascularization by optical coherence tomography. Graefes Arch Clin Exp Ophthalmol 2001;239:424-429.
22. Costa RA, Farah ME, Cardillo JA, et al. Immediate indocyanine green angiography and optical coherence tomography evaluation after photodynamic therapy for subfoveal choroidal neovascularization. Retina 2003;23:159-165.
23. Montero JA, Ruiz-Moreno JM, Tavolato M. Follow-up of age-related macular degeneration patients treated by photodynamic therapy with optical coherence tomography 3. Graefes Arch Clin Exp Ophthalmol 2003;241:797-802.
24. Polito A, Shah SM, Haller JA, et al. Comparison between retinal thickness analyzer and optical coherence tomography for assessment of foveal thickness in eyes with macular disease. Am J Ophthalmol 2002;134:240-251.